# Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy

> **NCT01955187** · PHASE3 · COMPLETED · sponsor: **Hospital Universitario 12 de Octubre** · enrollment: 86 (actual)

## Conditions studied

- MEMBRANOUS NEPHROPATHY

## Interventions

- **DRUG:** TACROLIMUS
- **DRUG:** RITUXIMAB
- **DRUG:** METHYLPREDNISOLONE
- **DRUG:** CYCLOPHOSPHAMIDE

## Key facts

- **NCT ID:** NCT01955187
- **Lead sponsor:** Hospital Universitario 12 de Octubre
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01
- **Primary completion:** 2019-06-26
- **Final completion:** 2019-06-26
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2020-01-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01955187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01955187, "Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01955187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*